Literature DB >> 8096125

Cardiovascular actions of ANF: contributions of renal, neurohumoral, and hemodynamic factors in sheep.

C J Charles1, E A Espiner, A M Richards.   

Abstract

Whereas the short-term effects of atrial natriuretic factor (ANF) are well documented, less is known concerning the possible hypotensive action of sustained low-dose ANF infusions. Accordingly, we have examined the sequential renal, hormonal, and hemodynamic responses to 48-h low-dose ANF infusions in eight normotensive conscious sheep and evaluated the effects of these infusions on autonomic (baroreceptor), adrenocortical, and pressor responsiveness to exogenous stimulation. Plasma ANF levels tended to rise in response to ANF infusions, but the difference between ANF and control day levels was not significantly different. Systolic arterial pressure (SAP) was significantly lower after ANF infusion (P = 0.01) and was associated with a reduction in calculated total peripheral resistance (CTPR, P = 0.007). Mean arterial pressure also tended to be lower (P = 0.08) in response to ANF. No change was seen in urinary volume or sodium excretion or in plasma angiotensin II (ANG II), aldosterone, or cortisol levels. ANF significantly attenuated the pressor response to exogenous ANG II (P = 0.01) but did not affect the adrenocortical responsiveness or autonomic (baroreceptor) responsiveness to exogenous stimulation. This study demonstrates that chronic low-dose infusions of ANF that barely elevate plasma ANF levels induce significant cardiovascular effects, including lowering of SAP associated with a fall in CTPR and attenuation of pressor responsiveness to physiological increments in ANG II, thus providing further support for the importance of ANF in blood pressure homeostasis in normal sheep.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8096125     DOI: 10.1152/ajpregu.1993.264.3.R533

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

Review 1.  Natriuretic Peptides and Cardiometabolic Health.

Authors:  Deepak K Gupta; Thomas J Wang
Journal:  Circ J       Date:  2015-06-23       Impact factor: 2.993

2.  Serum N-terminal pro-B-type natriuretic peptide levels are associated with functional capacity in patients with peripheral arterial disease.

Authors:  Jin Fan; Hayan Jouni; Mahyar Khaleghi; Kent R Bailey; Iftikhar J Kullo
Journal:  Angiology       Date:  2011-11-17       Impact factor: 3.619

3.  Plasma midregional pro-atrial natriuretic peptide is associated with blood pressure indices and hypertension severity in adults with hypertension.

Authors:  Mahyar Khaleghi; Umer Saleem; Nils G Morgenthaler; Stephen T Turner; Andreas Bergmann; Joachim Struck; Thomas H Mosley; Iftikhar J Kullo
Journal:  Am J Hypertens       Date:  2009-02-12       Impact factor: 2.689

4.  Performance of BNP and NT-proBNP for diagnosis of heart failure in primary care patients: a systematic review.

Authors:  Ronald A Booth; Stephen A Hill; Andrew Don-Wauchope; P Lina Santaguida; Mark Oremus; Robert McKelvie; Cynthia Balion; Judy A Brown; Usman Ali; Amy Bustamam; Nazmul Sohel; Parminder Raina
Journal:  Heart Fail Rev       Date:  2014-08       Impact factor: 4.214

Review 5.  B-type natriuretic peptide: physiologic role and assay characteristics.

Authors:  Hassan M E Azzazy; Robert H Christenson
Journal:  Heart Fail Rev       Date:  2003-10       Impact factor: 4.214

6.  Physiology and clinical significance of natriuretic hormones.

Authors:  Sandeep Chopra; Davis Cherian; Prashant Paul Verghese; Jubbin J Jacob
Journal:  Indian J Endocrinol Metab       Date:  2013-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.